CHANGES IN DNA METHYLATION PROFILE IN TAMOXIFEN-RESISTANT MCF-7 SUBLINES

Abstract Introduction. We have previously shown the feasibility of hormonal resistance horizontal distribution from cell to cell, with the joint cultivation of sensitive and resistant cells and/or through exosomes secreted by resistant cells. What is the mechanism of such resistance distribution, an...

Full description

Bibliographic Details
Main Authors:	О. Е. Andreeva, V. О. Sigin, V. V. Strelnikov, A. S. Tanas, A. M. Scherbakov, M. A. Krasilnikov
Format:	Article
Language:	Russian
Published:	Russian Academy of Sciences, Tomsk National Research Medical Center 2019-11-01
Series:	Сибирский онкологический журнал
Subjects:	breast cancer tamoxifen exosomes hormonal resistance methylation
Online Access:	https://www.siboncoj.ru/jour/article/view/1187

Similar Items

COMPARATIVE ANALYSIS OF THE EXOSOMAL CARGO OF THE ESTROGEN-RESISTANT BREAST CANCER CELLS
by: S. E. Semina, et al.
Published: (2018-09-01)

Tamoxifen Rechallenge Decreases Metastatic Potential but Increases Cell Viability and Clonogenicity in a Tamoxifen-Mediated Cytotoxicity-Resistant Subline of Human Breast MCF7 Cancer Cells
by: Yung-Chieh Chang, et al.
Published: (2020-06-01)

Intercellular interactions and progression of hormonal resistance of breast cancer cells
by: S. E. Semina, et al.
Published: (2015-06-01)

Exosome-Mediated Transfer of Cancer Cell Resistance to Antiestrogen Drugs
by: Svetlana E. Semina, et al.
Published: (2018-04-01)

Effect of Allicin on Tamoxifen-sensitive MCF-7 Breast Cancer Cells
by: P Rahimi-Moghaddam, et al.
Published: (2015-05-01)

TROP2 methylation and expression in tamoxifen-resistant breast cancer
by: Stephanie M. Zimmers, et al.
Published: (2018-07-01)

Induction of apoptosis by Elephantopus scaber L. ethanolic extract and effects of its interaction with tamoxifen on human breast cancer MCF-7 spheroids
by: Ho, Wan Yong
Published: (2012)

ROLE OF CYCLIN D1 IN THE MECHANISMS OF TAMOXIFEN RESISTANCE
by: D. B. Erdyneeva, et al.
Published: (2020-09-01)

Use of antipsychotics with tamoxifen
by: H. Ghabi, et al.
Published: (2021-04-01)

Hyper-ovulation, endometriosis, and hyperplasia associated with tamoxifen exposure in Swiss albino mice
by: Iman Ali Al-Anazy, et al.
Published: (2020-10-01)

The Investigation of the Effects of Tamoxifen and Vitamin D Combination on the Expression of P53, Bcl-2 and Bax and Cell Cycle in Mcf-7 Cell Line
by: Derya Yetkin, et al.
Published: (2018-12-01)

Impact of prolactin treatment on enhancing the cellular responses of MCF7 breast cancer cells to tamoxifen treatment
by: Anwar Shams
Published: (2024-12-01)

Enhancement of in vitro effects of polymeric nanoparticle encapsulated tamoxifin compared to tamoxifen in MCF-7 breast cancer cell line
by: Tung, En En
Published: (2012)

Induction of ovarian steroidogenesis as an additional potential risk factor for progression in premenopausal patients with hormone-receptor-positive breast cancer receiving tamoxifen as adjuvant therapy
by: A. Yu. Goryainova, et al.
Published: (2022-06-01)

Nuclear PRMT5 is a biomarker of sensitivity to tamoxifen in ERα+ breast cancer
by: Coralie Poulard, et al.
Published: (2023-07-01)

Repurposing of the Tamoxifen Metabolites to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli
by: Andrea Miró-Canturri, et al.
Published: (2021-03-01)

Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer
by: Liping Ye, et al.
Published: (2019-10-01)

Effect of tamoxifen in RAFT miniemulsion polymerization during the synthesis of polymer nanoparticles
by: Tailane Sant'Anna Moreira, et al.
Published: (2014-01-01)

Towards Unravelling the Role of ERα-Targeting miRNAs in the Exosome-Mediated Transferring of the Hormone Resistance
by: Olga E. Andreeva, et al.
Published: (2021-11-01)

Electrochemical biosensor for simultaneously detection of Tamoxifen
by: Hasret Subak
Published: (2022-12-01)

Bilateral Macular Edema in a Patient Treated with Tamoxifen: A Case Report and Review of the Literature
by: Paraskevas Zafeiropoulos, et al.
Published: (2014-12-01)

Features of ovarian steroidogenesis and endometrial hypertrophy during adjuvant therapy with tamoxifen in premenopausal patients with hormone-dependent breast cancer
by: A. Yu. Goryainova, et al.
Published: (2023-05-01)

Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan
by: Hiscox Stephen, et al.
Published: (2012-10-01)

The role of hormonal therapy in patients with relapsed high-grade ovarian carcinoma: a retrospective series of tamoxifen and letrozole
by: Angela George, et al.
Published: (2017-06-01)

Tamoxifen-induced acute pancreatitis – a case report
by: Rafał Czyżykowski, et al.
Published: (2014-03-01)

Combinatorial treatments of tamoxifen and SM6Met, an extract from Cyclopia subternata Vogel, are superior to either treatment alone in MCF-7 cells
by: Lorinda van Dyk, et al.
Published: (2022-09-01)

Effect of tamoxifen on the coronary vascular reactivity of spontaneously hypertensive female rats
by: M.V. Borgo, et al.
Published: (2011-08-01)

Effect of tamoxifen on the coronary vascular reactivity of spontaneously hypertensive female rats
by: M.V. Borgo, et al.
Published: (2011-08-01)

Role of follicle-stimulating hormone and estradiol benzoate in recovering spermatogenesis in tamoxifen-injured rats
by: Ali Olfati, et al.
Published: (2018-01-01)

MTDH Mediates Estrogen-Independent Growth and Tamoxifen Resistance by Down-Regulating PTEN in MCF-7 Breast Cancer Cells
by: Chunyuan Xu, et al.
Published: (2014-05-01)

Tamoxifen in horses: pharmacokinetics and safety study
by: Gonzalo Gajardo, et al.
Published: (2019-06-01)

Tamoxifen inhibits chemokinesis in equine neutrophils
by: Natalia Morales, et al.
Published: (2018-10-01)

Uniaxial and Coaxial Nanofibers PCL/Alginate or PCL/Gelatine Transport and Release Tamoxifen and Curcumin Affecting the Viability of MCF7 Cell Line
by: Diego Fernando Suárez, et al.
Published: (2022-09-01)

Which antidepressant agent can be used in patients receiving tamoxifen?
by: A. Maamri, et al.
Published: (2021-04-01)

Acquired Bilateral Nevoid Telangiectasia Induced by Tamoxifen
by: Irene Navarro Navarro, et al.
Published: (2023-04-01)

Tamoxifen in the Management of Breast Cancer: A Case Presented in Multidisciplinary Session With Clinical Discussion and Decision-Making
by: Marziyeh Ghalamkari, et al.
Published: (2019-02-01)

CD63+ Cancer‐Associated Fibroblasts Confer Tamoxifen Resistance to Breast Cancer Cells through Exosomal miR‐22
by: Yuan Gao, et al.
Published: (2020-11-01)

Tamoxifen-induced hyperosmolar hyperglycemic state secondary to suspected pancreatic beta cell inflammation
by: Billie Radovic, et al.
Published: (2020-12-01)

Agonistic activity of tamoxifen, a selective estrogen-receptor modulator (SERM), on arthritic ovariectomized mice
by: L.A.S. Silva, et al.
Published: (2017-11-01)

PTEN Gene Expression and Tamoxifen-Resistance in Steroid Hormone Receptor Positive Breast Cancer Patients, a cross-sectional study between 2006 and 2016
by: Fereshteh Mohammadi Daloyi, et al.
Published: (2020-04-01)